Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

Hughes, 2001, What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study, Neurology, 57, S34, 10.1212/WNL.57.8.1497 Hughes, 2002, The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, Brain, 125, 861, 10.1093/brain/awf080 Shih, 2007, Deep brain stimulation for the treatment of atypical parkinsonism, Mov Disord, 22, 2149, 10.1002/mds.21648 Deuschl, 2006, A randomized trial of deep-brain stimulation for Parkinson's disease, N Engl J Med, 355, 896, 10.1056/NEJMoa060281 2002, Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression, JAMA, 287, 1653, 10.1001/jama.287.13.1653 Jankovic, 2000, The evolution of diagnosis in early Parkinson disease, Arch Neurol, 57, 369, 10.1001/archneur.57.3.369 Fahn, 2004, Levodopa and the progression of Parkinson's disease, N Engl J Med, 351, 2498, 10.1056/NEJMoa033447 Gaenslen, 2008, The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study, Lancet Neurol, 7, 417, 10.1016/S1474-4422(08)70067-X Vlaar, 2008, The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans, BMC Neurol, 8, 42, 10.1186/1471-2377-8-42 Seppi, 2006, Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis, Arch Neurol, 63, 1154, 10.1001/archneur.63.8.1154 Brooks, 2009, Proposed neuroimaging criteria for the diagnosis of multiple system atrophy, Mov Disord, 24, 949, 10.1002/mds.22413 Chung, 2009, MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from parkinsonism-predominant multiple system atrophy, Mov Disord, 24, 1650, 10.1002/mds.22649 Eckert, 2007, Assessment of the progression of Parkinson's disease: a metabolic network approach, Lancet Neurol, 6, 926, 10.1016/S1474-4422(07)70245-4 Eidelberg, 2009, Metabolic brain networks in neurodegenerative disorders: a functional imaging approach, Trends Neurosci, 32, 548, 10.1016/j.tins.2009.06.003 Ma, 2007, Abnormal metabolic network activity in Parkinson's disease: test–retest reproducibility, J Cereb Blood Flow Metab, 27, 597, 10.1038/sj.jcbfm.9600358 Eckert, 2008, Abnormal metabolic networks in atypical parkinsonism, Mov Disord, 23, 727, 10.1002/mds.21933 Eckert, 2007, Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging, Mov Disord, 22, 167, 10.1002/mds.21185 Spetsieris, 2009, Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features, Neuroimage, 45, 1241, 10.1016/j.neuroimage.2008.12.063 Litvan, 2003, Movement Disorders Society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders, Mov Disord, 18, 467, 10.1002/mds.10459 Fahn, 2007, 233 Schrag, 1999, Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study, Lancet, 354, 1771, 10.1016/S0140-6736(99)04137-9 Papp, 1994, The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology, Brain, 117, 235, 10.1093/brain/117.2.235 Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 Litvan, 1996, Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders, J Neuropathol Exp Neurol, 55, 97, 10.1097/00005072-199601000-00010 Allison, 1999 Hastie, 2009, 219 Osaki, 2002, Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?, Neurology, 59, 1486, 10.1212/01.WNL.0000028690.15001.00 Osaki, 2004, Accuracy of clinical diagnosis of progressive supranuclear palsy, Mov Disord, 19, 181, 10.1002/mds.10680 Wenning, 2000, What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?, J Neurol Neurosurg Psychiatry, 68, 434, 10.1136/jnnp.68.4.434 Huang, 2007, Changes in network activity with the progression of Parkinson's disease, Brain, 130, 1834, 10.1093/brain/awm086 Poston, 2009, Longitudinal changes in regional metabolism and network activity in multiple system atrophy, Neurology, 72, A67